Aug 2026· European Heart Journal - Digital Health· Vol 7· 1 citation· 42 references
Medicine
TL;DR
Artificial intelligence-enhanced electrocardiography demonstrated good diagnostic performance for detecting LVDD and may support future rule-out or risk-enrichment strategies in selected populations, however, current evidence remains insufficient to support routine clinical implementation.
Abstract
Abstract Left ventricular diastolic dysfunction (LVDD) is an early precursor to heart failure with preserved ejection fraction, and it is currently diagnosed using echocardiography, a resource-intensive and operator-dependent modality that limits large-scale screening. The 12-lead electrocardiogram (ECG) is widely available but lacks sufficient diagnostic accuracy for LVDD. Artificial intelligence (AI)–enhanced ECG analysis has emerged as a potential scalable alternative, although its overall diagnostic performance remains uncertain. This study aims to evaluate the diagnostic accuracy of AI-based algorithms for detecting LVDD in a systematic review and meta-analysis. We systematically searched eight major databases through August 2025, complemented by forward and backward citation chasing. Studies reporting sensitivity and specificity of AI-ECG models, using echocardiography as the reference standard, were included. Pooled sensitivity, specificity, and area under the summary receiver operating characteristic curve (AUC) were estimated using a bivariate random-effects model. Five studies including 105 554 participants were analysed. AI-ECG demonstrated a pooled sensitivity of 0.82 (95% CI: 0.81–0.83) and specificity of 0.77 (95% CI: 0.70–0.82), with an AUC of 0.85 (95% CI: 0.81–0.87). Substantial heterogeneity was observed (I2 = 98.5% for sensitivity and 99.8% for specificity), although results were robust in sensitivity analyses. Predictive values were prevalence-dependent. Negative predictive value was 98.8% at 5% prevalence and 93.7% at 22.2%, but declined to 81.1% at 50% prevalence and 64.7% at 70%. Artificial intelligence–enhanced electrocardiography demonstrated good diagnostic performance for detecting LVDD and may support future rule-out or risk-enrichment strategies in selected populations. However, current evidence remains insufficient to support routine clinical implementation.
Adding AI-ECG signals to PREVENT-HF improves near-term heart-failure risk discrimination and reclassification, though without demonstrated benefit on clinical outcomes such as heart-failure hospitalization or mortality.
A. Bollmann, V. Pradler, D. Husser et al.· Frontiers in Cardiovascular...· 0 citations
Artificial intelligence-enabled single-lead wearable ECG screening may support earlier LVSD detection when integrated with validated algorithms, secure data systems, clinician oversight, and structured echocardiography referral pathways.
kehinde Tom-Ayegunle, Abutu Ann Oine, Idoko David Oche· International Journal of Sci...· 0 citations
The AI-ECG model accurately identified LVSD in ED patients in this cohort despite heterogeneous acquisition conditions and retained good discrimination in hemodynamically unstable subgroups, although findings in the smaller hypotensive subgroup should be interpreted as exploratory.
A composite artificial intelligence-enabled electrocardiogram (AI-ECG) identified prevalent and predicted incident Structural heart disease (SHD) across multinational cohorts, capturing signals beyond its training targets and supporting its potential as a scalable cardiovascular screening tool.
H. Lee, S. Kang, M. Lee et al.· medRxiv· 0 citations
AI-enabled ECG demonstrates high sensitivity and consistently excellent negative predictive value for AMI detection, supporting its role as a scalable, non-invasive triage adjunct at first medical contact and highlighting the potential of AI-ECG to facilitate early rule-out strategies and improve prioritization of pati...
G. Gaelzer, P. Batista, M. Montenegro et al.· European Heart Journal - Dig...· 0 citations
In this single-center exploratory cohort of patients with obstructive hypertrophic cardiomyopathy receiving mavacamten, ECG-Vision left ventricular demonstrated high observed sensitivity and negative predictive value for TTE-defined LVSD, although estimates were imprecise because LVSD events were infrequent.
Aakash Bavishi, John Fritzlen, Marybeth Soutar et al.· Circulation: Heart Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.